Schizophrenia Clinical Trial
Official title:
Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis (CBTp-E) in Reducing Delusions. A Randomized-controlled Treatment Study (CBTd-E)
The aim of the present single-blind randomized-controlled therapy study is to assess the efficacy of a new form of Cognitive Behavioral Therapy for delusions with a focus on emotion regulation, improvement of self-esteem and sleep quality (CBTd-E).
Numerous meta-analyses have found Cognitive Behaviour Therapy for psychosis (CBTp) to be
effective. The effect sizes that are achieved for positive symptoms in addition to
antipsychotic treatment vary between small to medium. However, the effect sizes for changes
in delusions are somewhat lower. Thus, it could prove beneficial to tailor CBTp interventions
more precisely to the processes that are relevant to delusions. Empirically derived models of
the formation and maintenance of delusions postulate an important role of cognitive biases,
emotional factors and self-esteem. Additional studies have demonstrated the relevance of
impaired sleep to delusions. Nevertheless, CBTp interventions that aim to change delusions
tend to focus mainly on reasoning bias.
The results of several uncontrolled pilot studies that focused primarily at improving
emotional factors, quality of sleep and self-esteem in patients with delusions indicate that
changes in these factors have the potential to reduce delusions. However, in these studies
the singular interventions were short and were not implemented into a broader therapy
rational. It can thus be assumed that a combination of CBT-interventions within a broader
therapy rational might have an even greater impact on delusions.
The aim of the present single-blind randomized-controlled therapy study is to assess the
efficacy of a new form of Cognitive Behavioral Therapy for delusions with a focus on emotion
regulation, improvement of self-esteem and sleep quality (CBTd-E) that will be applied in 25
individual sessions. Moreover, the study aims to test whether the efficacy of CBTd-E is
mediated by the postulated processes. The main hypotheses are:
1. Baseline differences: in comparison to healthy controls, patients with schizophrenia
show more pronounced problems in emotion regulation, a reduced sleep quality and a lower
and less stable self-esteem.
2. Efficacy of CBTd-E: patients with acute delusions who receive CBTd-E show a more
pronounced reduction of delusions (primary outcome), as well as a more pronounced
reduction of positive symptoms, depression and general psychopathology, a stronger
improvement in general and social functioning and will receive lower doses of
antipsychotic medication (secondary outcomes) at post-treatment.
3. Mediation: the effect of CBTd-E on change in delusions is mediated by a) improved
emotional stability and ability to regulate one's own emotions, b) improved sleep
quality, c) improved and more stable self-esteem.
In addition to questionnaires and interviews, behavioral paradigms, psychophysiological
assessments and electronic diaries will be used to test the hypotheses. If we can demonstrate
that CBTd-E reduces delusions, this would provide us with a more acceptable and feasible
therapy for treating delusions.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |